Delivery Order SPE2DB20D3104-SPE2DB21FV5N7
- Not listed
- The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,630.74, is a delivery order awarded by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) with Amerisourcebergen's parent company, Cencora, Inc. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to supply a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $1,490.40, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) held by the company's parent, Cencora, Inc., valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, with a ceiling value of $13,950.57, was awarded by the Defense Logistics Agency (DLA) as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support various government healthcare programs, particularly within the military and veterans' healthcare systems. The contract, valued at $1,834.44, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of a wide range of pharmaceutical products and medical supplies to support federal government healthcare programs. The contract, awarded by the Defense Logistics Agency (DLA), is a $3,059.96 delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $45,183.00, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This single-award IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver a comprehensive...
- This federal contract award is held by Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $2,216.51, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under an Indefinite Delivery Contract (IDC) with the company. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver essential...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to the U.S. government. The award, with a ceiling value of $1,286.44, was issued by the Defense Logistics Agency (DLA) and is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to deliver...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, from the Defense Logistics Agency (DLA) for the delivery of a wide range of pharmaceutical products and medical supplies. The contract, valued at $12,790.61, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide essential...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver a wide range of pharmaceutical products and medical supplies to the U.S. government. The $13,003.97 delivery order was issued by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB21FV5N7Delivery Order
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. government. The contract, valued at $7,556.17, was awarded by the Defense Logistics Agency (DLA) and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC serves as the primary vehicle for Amerisourcebergen to provide essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company, Cencora, Inc., also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 2/11/21 |